Armin Hofmeister

USPTO Granted Patents = 40 (Patent Applications = 9)

CIPO Patents = 2

EPO Patents = 16 (Patent Applications = 9)

Average Co-Inventor Count = 5.0

ph-index = 8

Forward Citations = 253(Granted Patents)

Location History:

Kriftel, DE (2006)
Nierstein, DE (2002 - 2009)
Frankurt am Main, DE (2010)
Oppenheim, DE (2004 - 2011)
Dexheim, DE (2010 - 2014)
Frankfurt-am-Main, DE (2011 - 2024)

Company Filing History:

15 out of 1,827

Sanofi-a Ventis Deutschland Gmbh

Aventis Pharma Deutschland, Gmbh

Years Active: 2002-2025

Loading Chart...

40 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12416004 - RNA compositions and methods for inhibiting ANGPTL8 (2025-09-16),

2. 11897911 - Nucleotide precursors, nucleotide analogs and oligomeric compounds containing the same (2024-02-13),

3. 9221828 - N-[4-(1H-pyrazolo[3,4-b]pyrazin-6-yl)phenyl]sulfonamides as pharmaceuticals (2015-12-29),

4. 9174993 - N-[4-(1H-pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides and their use as pharmaceuticals (2015-11-03),

5. 8796458 - Cyclohexylamine isoquinolone derivatives (2014-08-05),

6. 8748614 - Substituted isoquinoline and isoquinolinone derivatives (2014-06-10),

7. 8742116 - Cycloalkylamine substituted isoquinolone derivatives (2014-06-03),

8. 8722671 - Isoquinoline derivatives (2014-05-13),

9. 8710228 - Cycloalkylamine substituted isoquinoline derivatives (2014-04-29),

10. 8609691 - Cyclohexylamin isoquinolone derivatives (2013-12-17),

11. 8501736 - Isoquinoline derivatives (2013-08-06),

12. 8461144 - Substituted isoquinoline and isoquinolinone derivatives (2013-06-11),

13. 8278294 - Substituted isoquinoline and isoquinolinone derivatives as inhibitors of Rho-kinase (2012-10-02),

14. 8188117 - Piperidinyl-substituted isoquinolone derivatives (2012-05-29),

15. 8067614 - N-substituted (benzoimidazol-2-yl)phenylamines, processes for their preparation, their use as a medicament or diagnostic aid, and a medicament comprising them (2011-11-29),

Title: Armin Hofmeister: A Trailblazer in Pharmacological Innovation

Introduction: Armin Hofmeister, a visionary inventor hailing from Oppenheim, DE, has left an indelible mark on the world of pharmacology with his relentless pursuit of excellence and passion for innovation. With an impressive 38 patents under his belt, including groundbreaking pharmaceutical discoveries, he continues to inspire the next generation of inventors and shape the future of technology.

Latest Patents: Among his latest patents are the N-[4-(1H-pyrazolo[3,4-b]pyrazin-6-yl)phenyl]sulfonamides, valuable pharmacologically active compounds targeting the activity of serum and glucocorticoid regulated kinase (SGK). These compounds show promise in the treatment of various diseases such as degenerative joint disorders and inflammatory conditions like osteoarthritis and rheumatism. Armin's innovative approach to developing these compounds underscores his commitment to advancing healthcare through cutting-edge pharmaceutical solutions.

Career Highlights: Armin Hofmeister's illustrious career has seen him collaborate with renowned companies such as Sanofi and Ventis Deutschland Gmbh. His tenure at these esteemed organizations has been marked by groundbreaking research and innovative breakthroughs in the field of pharmacology. Armin's relentless dedication to pushing the boundaries of scientific discovery has earned him a reputation as a pioneering force in the industry.

Collaborations: Throughout his career, Armin has worked alongside esteemed colleagues such as Uwe Heinelt and Hans-Jochen Lang, both of whom have contributed significantly to his research endeavors. Together, they have spearheaded projects that have revolutionized the landscape of pharmacological innovation, paving the way for novel treatment modalities and therapeutic interventions.

Conclusion: In conclusion, Armin Hofmeister's legacy as a trailblazer in pharmacological innovation continues to inspire and influence aspiring inventors worldwide. His unwavering commitment to excellence and his groundbreaking contributions to the field of pharmaceutical research have positioned him as a visionary leader who is shaping the future of technology and healthcare. Armin's remarkable achievements serve as a testament to the power of innovation and the transformative impact it can have on society.

This text is generated by artificial intelligence and may not be accurate.